ImmunoGen, Inc. Announces Webcast Of Presentations At Upcoming Investor Conferences

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the following presentations by Company management at upcoming investor conferences will be webcast:

•Leerink Swann Global Healthcare Conference

8:30 am ET, February 13 in New York, NY

Help employers find you! Check out all the jobs and post your resume.